ClassID:

21256

A61K45/06 - page 4 - CPC Classification

Classification description:

Medicinal preparations containing active ingredients not provided for in groups  -  Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Recent Application in this class:
#901
20260007770
2026-01-08

REVERSED MICELLES FOR DELIVERY OF HYDROPHILIC DRUGS

#902
20260007764
2026-01-08

USE OF A CONJUGATE OF ANTI-CD47 ANTIBODY AND TOLL-LIKE RECEPTOR AGONIST

#903
20260007762
2026-01-08

ANTI-ROR2 ANTIBODY-DRUG CONJUGATES

#904
20260007743
2026-01-08

Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof

#905
20260007742
2026-01-08

METHODS FOR TREATING DIGITALLY-IDENTIFIED IL-4/IL-13 RELATED DISORDERS BY ADMINISTERING AN ANTI-IL4R-ALPHA ANTIBODY

#906
20260007737
2026-01-08

LIPID POLYSACCHARIDE AMINO ACID NANOPARTICLES AND USE THEREOF

#907
20260007720
2026-01-08

TISSUE REGENERATIVE MULTI-DRUG COCKTAIL AND APPARATUS FOR DELIVERY THEREOF

#908
20260007719
2026-01-08

COMPOSITION FOR INTERMITTENT DOSING OF CALCINEURIN INHIBITORS

#909
20260007717
2026-01-08

ANTIMICROBIAL PEPTIDE COMPOUNDS AND METHODS OF USE

#910
20260007704
2026-01-08

MICROBIAL CONSORTIA

#911
20260007686
2026-01-08

COMPOSITIONS AND METHODS FOR IMPROVING VISION

#912
20260007682
2026-01-08

NASAL COMPOSITIONS COMPRISING ALCAFTADINE

#913
20260007679
2026-01-08

METHODS OF TREATING CANCER USING 3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE

#914
20260007676
2026-01-08

HDAC INHIBITORS FOR USE WITH NK CELL BASED THERAPIES

#915
20260007675
2026-01-08

TARGETING CHROMATIN REGULATORS INHIBITS LEUKEMOGENIC GENE EXPRESSION IN NPM1 MUTANT LEUKEMIA

#916
20260007668
2026-01-08

AMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF

#917
20260007658
2026-01-08

METHOD OF PROVIDING ARIPIPRAZOLE TO PATIENTS HAVING IMPAIRED CYP2D6 OR CYP3A4 ENZYME FUCTION

#918
20260007656
2026-01-08

METHODS AND COMPOSITIONS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMA, PNEUMONIA, BRONCHITIS, CYSTIC FIBROSIS, PULMONARY EDEMA, INTERSTITIAL LUNG DISEASE, SARCOIDOSIS, IDIOPATHIC PULMONARY FIBROSIS, ACUTE RESPIRATORY DISTRESS SYNDROME, PULMONARY ARTERIAL HYPERTENSION, ADN RESPIRATORY SYNCYTIAL VIRUS

#919
20260007635
2026-01-08

INHIBITION OF DIPEPTIDE REPEAT PROTEINS

#920
20260007620
2026-01-08

METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS

#921
20260007617
2026-01-08

METHOD FOR TREATING RENAL CELL CARCINOMA OR CANCER

#922
20260007615
2026-01-08

PARTICLES COMPRISING A THERAPEUTIC OR DIAGNOSTIC AGENT AND SUSPENSIONS AND METHODS OF USE THEREOF

#923
20260007611
2026-01-08

ULTRASOUND RESPONSIVE NANOCLUSTER FOR CANCER TREATMENT AND METHOD FOR MANUFACTURING THE SAME

#924
20260007599
2026-01-08

TICAGRELOR IV FORMULATIONS FOR USE IN THE TREATMENT OF GRAM-POSITIVE BACTEREMIA

#925
20260007597
2026-01-08

COMPOSITIONS AND METHODS FOR TREATMENT OF VIRUS-INDUCED AIRWAY FIBROSIS

#926
20260007594
2026-01-08

DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS

#927
20260002945
2026-01-01

METHODS OF TREATING, AMELIORATING AND/OR PREVENTING WOUNDS

#928
20260002222
2026-01-01

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF ALT CANCER

#929
20260002214
2026-01-01

PERSONALIZED TUMOR MARKERS

#930
20260001955
2026-01-01

Methods of Treating PD-L1 Expressing Cancer

#931
20260001942
2026-01-01

TREATMENT OF HEADACHE DISORDERS AND/OR PSYCHIATRIC SYMPTOMS USING ANTI-CGRP ANTIBODIES, AND COMPOSITIONS AND METHODS RELATED THERETO

#932
20260001933
2026-01-01

PROTEINS COMPRISING THE EXTRACELLULAR DOMAIN OF P75NTR

#933
20260001924
2026-01-01

NEMO COILED COIL MIMICS AND METHODS OF USING SAME

#934
20260001898
2026-01-01

Heteroaryl compounds as inhibitors of TYK2/JAK1, composition and application thereof

#935
20260001893
2026-01-01

SMALL MOLECULE MODULATORS OF STAT6

#936
20260001873
2026-01-01

NOVEL INHIBITORS

#937
20260001862
2026-01-01

QUINOXALINEDIONE AND PYRIDO[2,3-B]PYRAZINE-2,3-DIONE B CELL LYMPHOMA 6 (BCL6) DEGRADERS AND USES THEREOF

#938
20260001844
2026-01-01

COMPOUNDS AND METHODS FOR THE TREATMENT AND PREVENTION OF HIV

#939
20260000781
2026-01-01

FC CONJUGATES INCLUDING AN INHIBITOR OF CD73 AND USES THEREOF

#940
20260000769
2026-01-01

LYMPH DIRECTING PRODRUGS

#941
20260000768
2026-01-01

APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS

#942
20260000745
2026-01-01

COMPOSITION FOR PREVENTING OR TREATING CANCER, AND METHOD FOR PREVENTING OR TREATING CANCER BY USING SAME, HAVING ABSCOPAL EFFECT

#943
20260000741
2026-01-01

METHOD OF AMELIORATING A PRO-INFLAMMATORY IMMUNOPHENOTYPE IN FARBER DISEASE SUBJECTS BY REPEATED ADMINISTRATION OF A RECOMBINANT HUMAN ACID CERAMIDASE

#944
20260000714
2026-01-01

C. NOVYI FOR THE TREATMENT OF SOLID TUMORS IN NON-HUMAN ANIMALS

#945
20260000713
2026-01-01

MICROBIAL METABOLITES ON INTESTINAL INFLAMMATION

#946
20260000703
2026-01-01

COMPOUNDS, COMPOSITIONS, AND METHODS FOR REDUCING PRODUCTION OF TRIMETHYLAMINE

#947
20260000701
2026-01-01

SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

#948
20260000696
2026-01-01

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#949
20260000688
2026-01-01

CANNABINOID COMPOSITIONS AND METHODS OF USING

#950
20260000687
2026-01-01

CANNABINOID COMPOSITIONS AND METHODS OF USING

#951
20260000682
2026-01-01

COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE

#952
20260000675
2026-01-01

COMBINATION THERAPY FOR PREVENTING OR TREATING OBESITY

#953
20260000673
2026-01-01

BRAIN HEALTH SUPPLEMENT

#954
20260000672
2026-01-01

HISTONE DEACETYLASE INHIBITORS FOR USE IN IMMUNOTHERAPY

#955
20260000658
2026-01-01

METHODS FOR THE TREATMENT OF PROLIFERATIVE GLOMERULONEPHRITIS

#956
20260000646
2026-01-01

Inhibition of Oral Microbe Biofilms

#957
20260000643
2026-01-01

Combination Of Curaxins And Immune Checkpoint Inhibitors For Treating Cancer

#958
20260000641
2026-01-01

ISOTOPICALLY ENRICHED ANALOGS OF 5,6-METHYLENEDIOXY-2-AMINOINDANE (IMDAI)

#959
20260000640
2026-01-01

COMPOSITIONS AND METHODS FOR SKIN CARE

#960
20260000632
2026-01-01

STRUCTURALLY MODIFIED FATTY ACIDS FOR IMPROVING GLYCEMIC CONTROL AND TREATING INFLAMMATORY BOWEL DISEASE

#961
20260000615
2026-01-01

MULTIPHASE ACTIVE SUBSTANCE PREPARATIONS

#962
20260000609
2026-01-01

METHODS AND COMPOSITIONS FOR TARGETED DELIVERY BY POLYMERSOMES

#963
20250388959
2025-12-25

MULTI-MODALITY PLATFORM IMMUNOTHERAPY AND TUMOR-SPECIFIC T CELLS

#964
20250388900
2025-12-25

Compositions and Methods for Inhibition of Factor XII Gene Expression

#965
20250388899
2025-12-25

RNA INTERFERENCE OLIGONUCLEOTIDES FOR INHIBITING PERINEURONAL NETWORK FORMATION

#966
20250388693
2025-12-25

Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses

#967
20250388668
2025-12-25

ANTIBODIES AGAINST ILT2 AND USE THEREOF

#968
20250388666
2025-12-25

HUMANIZED AND AFFINITY-MATURED ANTI-CEACAM1 ANTIBODIES AND METHODS OF USE

#969
20250388615
2025-12-25

SUBSTITUTED 4-PHENYL PYRIDINE COMPOUNDS AS NON-SYSTEMIC TGR5 AGONISTS

#970
20250388602
2025-12-25

Tetrahydropyranopyrazole Derivatives for the Treatment of Cancer and Viral Infections

#971
20250388591
2025-12-25

TRICYCLIC COMPOUNDS AND USES THEREOF

#972
20250388589
2025-12-25

TRICYCLIC HETEROCYCLIC DERIVATIVES, COMPOSITIONS AND USES THEREOF

#973
20250388585
2025-12-25

PRMT5 INHIBITORS AND USES THEREOF

#974
20250388554
2025-12-25

ANTIBACTERIAL COMPOUNDS, METHOD OF PRODUCTION AND USE THEREOF

#975
20250388529
2025-12-25

N-Substituted Phenylalkylamines and Their Use as Therapeutic Agents

#976
20250387488
2025-12-25

ACTIVE AGENT-ELUTING HEMOSTATIC AGENTS AND METHODS OF USE THEREOF

#977
20250387485
2025-12-25

FORMULATIONS AND USES THEREOF

#978
20250387484
2025-12-25

CD25-SPECIFIC ANTIBODIES AND USES THEREOF

#979
20250387454
2025-12-25

USES OF PTHRP ANALOGUE IN REDUCING FRACTURE RISK

#980
20250387453
2025-12-25

Methods and Compositions for Treating Diabetes

#981
20250387449
2025-12-25

PHARMACEUTICAL COMBINATION COMPRISING AN IBAT INHIBITOR AND A BILE ACID BINDER

#982
20250387427
2025-12-25

Compositions and Methods of Treatment for Various Conditions using High-Molecular Weight Hyaluronic Acid

#983
20250387423
2025-12-25

INJECTABLE ANTIBIOTIC FORMULATIONS AND USES THEREOF

#984
20250387420
2025-12-25

Prevention of Nausea and Vomiting from Antibody-Drug Conjugates and other Long-Acting Emetogenics

#985
20250387418
2025-12-25

USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY

#986
20250387405
2025-12-25

PHARMACEUTICAL COMPOSITION CONTAINING PLATINUM DRUGS OR PLATINUM DRUG COCRYSTALS, AND USE THEREOF

#987
20250387396
2025-12-25

TREATING EXTRAPYRAMIDAL SYNDROME USING TRAPIDIL

#988
20250387393
2025-12-25

ORAL COMPOSITIONS OF MK2 PATHWAY INHIBITOR FOR TREATMENT OF IMMUNE CONDITIONS

#989
20250387390
2025-12-25

METHODS FOR TREATING FIBROSIS USING PKM2 ACTIVATORS

#990
20250387384
2025-12-25

ARIMOCLOMOL FOR TREATING GLUCOCEREBROSIDASE ASSOCIATED DISORDERS

#991
20250387383
2025-12-25

METHODS OF TREATING MYELOPROLIFERATIVE NEOPLASMS

#992
20250387370
2025-12-25

USE OF TRANS-[TETRACHLOROBIS(1H-INDAZOLE)RUTHENATE(III)] FOR THE TREATMENT OF CANCER

#993
20250387368
2025-12-25

PREVENTING AND TREATING MALARIA

#994
20250387362
2025-12-25

COMPOSITIONS FOR AND METHODS OF PRECISION CANCER TREATMENT

#995
20250387337
2025-12-25

CONSUMER PRODUCT TABLET USING DIRECT COMPRESSION

#996
20250382635
2025-12-18

GENERATION OF NEURONS BY REPROGRAMMING OF OLIGODENDROCYTES AND OLIGODENDROCYTE PRECURSOR CELLS

#997
20250382619
2025-12-18

CANCER THERAPY WITH TGF-BETA-2 AND IRINOTECAN AGENTS

#998
20250382569
2025-12-18

GENERATION OF NEURONS BY REPROGRAMMING OF OLIGODENDROCYTES AND OLIGODENDROCYTE PRECURSOR CELLS

#999
20250382372
2025-12-18

ANTI-CD1A ANTIBODIES

#1000
20250382370
2025-12-18

ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE

#1001
20250382365
2025-12-18

ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF

#1002
20250382332
2025-12-18

NOVEL ALPHA-FACTOR BASED PEPTIDES WITH ANTIFUNGAL ACTIVITY

#1003
20250382293
2025-12-18

COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR

#1004
20250382292
2025-12-18

COMPOUNDS FOR TREATING LIGHT CHAIN AMYLOIDOSIS

#1005
20250382279
2025-12-18

COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR

#1006
20250381294
2025-12-18

Compositions of DNA Molecules Encoding Factor VIII, Methods of Making Thereof, and Methods of Use Thereof

#1007
20250381244
2025-12-18

METHODS AND COMPOSITIONS FOR IMMUNOMODULATION

#1008
20250381240
2025-12-18

COMPOSITIONS AND METHODS FOR HAIR TREATMENT

#1009
20250381220
2025-12-18

MAGNESIUM-L-THREONATE AND NEUROTRANSMITTER COMPOSITIONS AND RELATED METHODS

#1010
20250381209
2025-12-18

COMBINATION THERAPY FOR HIV WITH ADENOSINE DERIVATIVE AND CAPSID INHIBITORS

#1011
20250381204
2025-12-18

A CANNABINOID MIXTURE WITH TERPENES FOR THE TREATMENT OF ANXIETY

#1012
20250381199
2025-12-18

PHARMACEUTICAL PREPARATION FOR IMPROVING ABSORPTION AND POSTPRANDIAL HYPOGLYCEMIC ACTION OF INSULIN

#1013
20250381196
2025-12-18

ALPHA PROTEIN KINASE 1 INHIBITORS FOR USE IN TREATING KIDNEY DISEASES AND KIDNEY-RELATED DISEASES

#1014
20250381195
2025-12-18

Methods of Treating Diabetic Macular Edema

#1015
20250381188
2025-12-18

METHODS OF TREATING AND PREVENTING ALLOANTIBODY DRIVEN CHRONIC GRAFT VERSUS HOST DISEASE

#1016
20250381172
2025-12-18

NOVEL DOSAGE AND FORMULATION

#1017
20250381166
2025-12-18

Cannabis-Derived Flavonoids And Related Methods

#1018
20250381163
2025-12-18

Chelating Agents for Use in Cancer Therapy

#1019
20250381161
2025-12-18

COMPOSITIONS AND METHODS FOR TREATING HEARING AND OCULAR DISORDERS

#1020
20250381158
2025-12-18

MAGNESIUM COMPOSITIONS AND USES THEREOF FOR NEUROLOGICAL DISORDERS

#1021
20250381157
2025-12-18

ANTIMICROBIAL COMPOUNDS

#1022
20250381156
2025-12-18

TREATMENT OR PREVENTION OF CARDIOVASCULAR EVENTS VIA THE ADMINISTRATION OF A COLCHICINE DERIVATIVE

#1023
20250381139
2025-12-18

MULTI-TAIL TYPE IONIZABLE LIPID, PREPARATION METHOD THEREFOR AND USE THEREOF

#1024
20250381136
2025-12-18

DELIVERY SYSTEM

#1025
20250381074
2025-12-18

NASAL PASSAGE INSERT AND PACKAGING ASSEMBLY THEREFOR

#1026
20250378926
2025-12-11

METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS

#1027
20250377365
2025-12-11

METHODS INVOLVING DETECTING TNF STIMULATED GENE 6 (TSG-6) FOR IMPROVING ANTI-TUMOR RESPONSES TO IMMUNE THERAPY IN CANCER PATIENTS

#1028
20250376733
2025-12-11

METHODS FOR DIAGNOSING AND TREATING CANCER BY MEANS OF THE EXPRESSION STATUS AND MUTATIONAL STATUS OF NRF2 AND DOWNSTREAM TARGET GENES OF SAID GENE

#1029
20250376533
2025-12-11

ANTI-CD40 ANTIBODY, ANTI-PD-L1×CD40 BISPECIFIC ANTIBODY, AND USE THEREOF

#1030
20250376531
2025-12-11

ANTI-4-1BB ANTIBODIES AND METHODS OF MAKING AND USING THEREOF

#1031
20250376522
2025-12-11

Targeting Cells with a Combination of CXCR2 Inhibition and CD47 Blockade

#1032
20250376520
2025-12-11

Anti-TRPM4 Antibody For Treating Stroke

#1033
20250376514
2025-12-11

SIGNATURE OF TL1A (TNFSF15) SIGNALING PATHWAY

#1034
20250376507
2025-12-11

NOVEL TUMOR ANTIGEN-TARGETING ANTICANCER AGENT

#1035
20250376505
2025-12-11

BK VIRUS NEUTRALIZING ANTIBODIES

#1036
20250376504
2025-12-11

BK VIRUS NEUTRALIZING ANTIBODIES

#1037
20250376458
2025-12-11

COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR

#1038
20250376450
2025-12-11

COMPOUNDS AND COMPOSITIONS FOR EYE TREATMENTS

#1039
20250376445
2025-12-11

COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR

#1040
20250375501
2025-12-11

IMMUNOTHERAPY FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY BOWEL DISEASE

#1041
20250375493
2025-12-11

OKRA-DERIVED ANTIVIRAL COMPOSITION AND USES THEREOF

#1042
20250375489
2025-12-11

Combination Therapy for Treatment of Muscle Loss Due to Obesity Treatments

#1043
20250375488
2025-12-11

COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

#1044
20250375475
2025-12-11

PHARMACEUTICAL COMPOSITION AND METHODS FOR MODULATING INFLAMMATION AND OXIDATIVE STRESS

#1045
20250375458
2025-12-11

COMPOSITIONS AND METHODS TO COMBAT MULTIDRUG-RESISTANT AND PERSISTENT T-CELL-MEDIATED, ONCOLOGICAL AND INFECTIOUS DISEASES

#1046
20250375452
2025-12-11

SOTORASIB DOSING REGIMEN

#1047
20250375447
2025-12-11

TREATMENT OF CANCER UTILIZING AN IDENTIFIED ADENOSINE FINGERPRINT

#1048
20250375445
2025-12-11

METHODS OF TREATING A RAS PROTEIN-RELATED DISEASE OR DISORDER

#1049
20250375444
2025-12-11

METHOD OF TREATING ALZHEIMER’S DISEASE

#1050
20250375438
2025-12-11

PHARMACEUTICAL RESINATE COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF

#1051
20250375434
2025-12-11

SMALL MOLECULES AND METHODS FOR INDUCING CARDIOMYOCYTE PROLIFERATION

#1052
20250375432
2025-12-11

COMPOUNDS THAT MODULATES AMPA RECEPTOR FUNCTION

#1053
20250375429
2025-12-11

OBLIGATE PAIRING OF ORTHOSTERIC AND NON-ORTHOSTERIC GABA LIGANDS IN PHARMACEUTICAL FORMULATIONS

#1054
20250375418
2025-12-11

1-(NAPHTHALEN-2-YL)-3-AZABICYCLO[3.1.0]HEXANE FOR TREATING MAJOR DEPRESSIVE DISORDER

#1055
20250375415
2025-12-11

ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS

#1056
20250375402
2025-12-11

METHODS AND COMPOSITIONS FOR TREATMENT OF DISEASES

#1057
20250375394
2025-12-11

METHODS AND COMPOSITIONS FOR MODIFYING MUCOUS MEMBRANES

#1058
20250375374
2025-12-11

SHEAR-THINNING COMPOSITIONS FOR ABLATION

#1059
20250368999
2025-12-04

SOLUBLE INTERLEUKIN-7 RECEPTOR (SIL7R) MODULATING THERAPY TO TREAT CANCER

#1060
20250368750
2025-12-04

SHP INHIBITOR COMPOSITIONS AND USES FOR CHIMERIC ANTIGEN RECEPTOR THERAPY

#1061
20250368749
2025-12-04

COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS

#1062
20250368739
2025-12-04

Antibodies Directed Against T Cell Immunoglobulin and Mucin Protein 3 (TIM-3)

#1063
20250368722
2025-12-04

MULTISPECIFIC ANTIBODIES TARGETING MULTIPLE EPITOPES ON THE HIV-1 ENVELOPE

#1064
20250368687
2025-12-04

SHORT SYNTHETIC PEPTIDES AND USES THEREOF IN THE TREATMENT OF ENTEROVIRUS INFECTION

#1065
20250368677
2025-12-04

CD73 INHIBITORS

#1066
20250368659
2025-12-04

Antiviral Heterocyclic Compounds

#1067
20250368655
2025-12-04

SMALL MOLECULE INHIBITORS OF BCR-ABL

#1068
20250368648
2025-12-04

MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF

#1069
20250368640
2025-12-04

MULTIPLE KINASE DEGRADERS, COMPOSITIONS COMPRISING THE DEGRADER, AND METHODS OF USING THE SAME

#1070
20250368617
2025-12-04

NOVEL RAS INHIBITORS

#1071
20250368614
2025-12-04

COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR

#1072
20250368608
2025-12-04

SELECTIVE HDAC6 INHIBITOR

#1073
20250367304
2025-12-04

FAP-ACTIVATED PROTEASOME INHIBITORS FOR TREATING SOLID TUMORS

#1074
20250367299
2025-12-04

GAMMA-HYDROXYBUTYRATE DELIVERING COMPOUNDS AND PROCESSES FOR MAKING AND USING THEM

#1075
20250367295
2025-12-04

FAST-ACTING PLANT-BASED MEDICINAL COMPOUNDS AND NUTRITIONAL SUPPLEMENTS

#1076
20250367287
2025-12-04

COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR

#1077
20250367271
2025-12-04

COMPOSITIONS FOR TREATING ADDICTION

#1078
20250367267
2025-12-04

TREATING AUTOIMMUNE DISEASES WITH INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR LIGAND CONJUGATED TO AN AGENT

#1079
20250367261
2025-12-04

GOSERELIN IMPLANT DOSING REGIMENS FOR IMPROVED PATIENT COMPLIANCE

#1080
20250367259
2025-12-04

MODIFIED THERAPEUTIC AGENTS, STAPLED PEPTIDE LIPID CONJUGATES, AND COMPOSITIONS THEREOF

#1081
20250367246
2025-12-04

IMMUNOMODULATORY COMPOSITIONS COMPRISING MICROBIAL ENTITIES

#1082
20250367221
2025-12-04

METHODS OF CONDITIONING PATIENTS FOR T CELL THERAPY

#1083
20250367217
2025-12-04

PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY

#1084
20250367216
2025-12-04

PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY

#1085
20250367206
2025-12-04

1-METHYLXANTHINE-BASED BIOACTIVE COMPOSITION AND METHOD OF USE THEREOF

#1086
20250367203
2025-12-04

METHODS OF TREATING EPILEPSY AND REDUCING THE INCIDENCE OF SEIZURES

#1087
20250367191
2025-12-04

TREATMENT OF MITOCHONDRIAL DISEASES WITH A CNS-PENETRANT SGC STIMULATOR ZAGOCIGUAT

#1088
20250367188
2025-12-04

COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS

#1089
20250367179
2025-12-04

COMPOSITION AND METHODS FOR TREATING HERITABLE PULMONARY ARTERY HYPERTENSION ASSOCIATED WITH NONSENSE MUTATIONS

#1090
20250367170
2025-12-04

TOPICAL ANGIOTENSIN II RECEPTOR BLOCKERS (ARBS) FOR TREATING EYE CONDITIONS

#1091
20250367169
2025-12-04

FORMULATIONS FOR PERSONALIZED METHODS OF TREATMENT

#1092
20250367164
2025-12-04

THERAPEUTIC COMPOSITIONS FOR SKIN DISORDERS AND WOUND REPAIR

#1093
20250367154
2025-12-04

FORMULATIONS FOR PROMOTING HYDRATION AND METHODS OF USE THEREOF

#1094
20250367152
2025-12-04

Inducing Proliferation of Cardiomyocytes and Therapeutic Uses Related Thereto

#1095
20250367141
2025-12-04

METHODS FOR TREATING CANCER

#1096
20250367140
2025-12-04

METHODS FOR TREATING CANCER

#1097
20250367123
2025-12-04

PULSATILE DRUG DELIVERY SYSTEM FOR TREATING MORNING AKINESIA

#1098
20250367109
2025-12-04

DEVICES, SYSTEMS, AND METHODS FOR IMPROVED BONE REMODELING

#1099
20250362286
2025-11-27

SCREENING MODELS AND METHODS OF CANCER TREATMENT

#1100
20250361499
2025-11-27

Thrombolytic Protease Resistant ADAMTS13 Mutants

#1101
20250361360
2025-11-27

PH-SWITCHABLE HYDROGEL

#1102
20250361307
2025-11-27

COMBINATION THERAPIES FOR TREATING HYPERPROLIFERATIVE DISORDERS

#1103
20250361297
2025-11-27

ANTI- SIGLEC-15 BINDING MOLECULES AND METHODS OF USE

#1104
20250361252
2025-11-27

APOMORPHINE PRODRUGS AND USES THEREOF

#1105
20250361236
2025-11-27

DIACYLGLYCEROL KINASE MODULATING COMPOUNDS

#1106
20250361223
2025-11-27

AMIDE COMPOUNDS AND USES THEREOF

#1107
20250361206
2025-11-27

4-PIVALOYLOXY-N-METHYLTRYPTAMMONIUM CHLORIDE

#1108
20250361205
2025-11-27

ENZYME-CLEAVABLE METHADONE PRODRUGS AND METHODS OF USE THEREOF

#1109
20250360219
2025-11-27

CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME

#1110
20250360215
2025-11-27

PHARMACEUTICAL COMBINATIONS AND METHODS FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES

#1111
20250360210
2025-11-27

IMMUNOEFFECTOR CELLS DERIVED FROM INDUCED PLURIPOTENT STEM CELLS GENETICALLY ENGINEERED WITH MEMBRANE BOUND IL12 AND USES THEREOF

#1112
20250360208
2025-11-27

USE OF GLUTAMATE MODULATING AGENTS WITH IMMUNOTHERAPIES TO TREAT CANCER

#1113
20250360207
2025-11-27

METHODS FOR TREATING LUPUS NEPHRITIS USING FCRN ANTAGONISTS

#1114
20250360181
2025-11-27

USE OF CYCLOSPORINE ANALOGUES FOR TREATING FIBROSIS

#1115
20250360180
2025-11-27

ECHINOCANDIN COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF

#1116
20250360178
2025-11-27

ORGANIC PAIN RELIEF AND HAIR GROWTH COMPOSITION

#1117
20250360164
2025-11-27

METHOD FOR REDUCING THE INCIDENCE OF PECTORAL MYOPATHY IN POULTRY FEED

#1118
20250360163
2025-11-27

Therapeutic Composition and Methods

#1119
20250360157
2025-11-27

CYTOTOXIC FLUOROPYRIMIDINE POLYMERS AND METHODS OF USE THEREOF

#1120
20250360154
2025-11-27

DEOXYNUCLEOSIDE THERAPY FOR DISEASES CAUSED BY UNBALANCED NUCLEOTIDE POOLS INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES

#1121
20250360144
2025-11-27

DOSING REGIMEN FOR SEDATION WITH CNS 7056 (REMIMAZOLAM)

#1122
20250360141
2025-11-27

PYRIDINE DERIVATIVES WITH N-LINKED CYCLIC SUBSTITUENTS AS cGAS INHIBITORS

#1123
20250360140
2025-11-27

NOVEL METHODS

#1124
20250360137
2025-11-27

ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES

#1125
20250360136
2025-11-27

Treatment or Reversal of Treatment Resistant Depression and Related Central Nervous System (CNS) Inflammatory Conditions with a JAK Inhibitor

#1126
20250360124
2025-11-27

NOVEL RAS INHIBITORS

#1127
20250360111
2025-11-27

COMPOSITIONS OF AGPAT4 INHIBITORS AND METHODS OF USING THEREOF TO TREAT CANCER

#1128
20250353923
2025-11-20

ANTI-CD38 FUSION PROTEIN FORMULATION

#1129
20250353918
2025-11-20

TREATMENT OF ATOPIC DERMATITIS

#1130
20250353916
2025-11-20

TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR

#1131
20250353913
2025-11-20

ANTI-HLA-G ANTIBODIES, COMPOSITIONS COMPRISING ANTI-HLA-G ANTIBODIES AND METHODS OF USING ANTI-HLA-G ANTIBODIES

#1132
20250353912
2025-11-20

COMPOSITIONS AND METHODS COMPRISING ANTIBODIES THAT BIND TO COVALENT PEPTIDE CONJUGATES

#1133
20250353887
2025-11-20

Keratin Protein Extracts, Compositions, Methods and Uses Thereof

#1134
20250353863
2025-11-20

TRICYCLIC SPIROLACTAM COMPOUNDS WITH ANTIMYCOBACTERIAL ACTIVITY

#1135
20250353862
2025-11-20

C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER

#1136
20250353809
2025-11-20

NITROGEN-CONTAINING CHAIN COMPOUND, PREPARATION METHOD, COMPOSITION CONTAINING SAID COMPOUND, AND USE THEREOF

#1137
20250352663
2025-11-20

Nanoclusters Functionalized with Adenosine Triphosphate or an Analogue and Their Use

#1138
20250352662
2025-11-20

ANTIBODY DRUG CONJUGATES COMPRISING STING AGONISTS

#1139
20250352655
2025-11-20

THERAPEUTIC ANNEXIN-DRUG CONJUGATES AND METHODS OF USE

#1140
20250352652
2025-11-20

COMPOUNDS AND METHODS FOR THE TREATMENT AND PREVENTION OF FIBROTIC DISEASE STATES AND CANCER

#1141
20250352650
2025-11-20

TOPICAL COMPOSITION

#1142
20250352646
2025-11-20

ENGINEERED VIRUS

#1143
20250352614
2025-11-20

PEPTIDE THERAPEUTICS FOR THE TREATMENT OF CANCER AND USES THEREOF

#1144
20250352577
2025-11-20

TUMOR NEOANTIGENIC PEPTIDES AND USES THEREOF

#1145
20250352551
2025-11-20

SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS AND SECOND ACTIVE AGENTS FOR COMBINED USE

#1146
20250352549
2025-11-20

SUBSTITUTED HETEROCYCLIC COMPOUND DERIVATIVES AND THEIR PHARMACEUTICAL USE

#1147
20250352547
2025-11-20

Cancer Diagnostic and Treatment

#1148
20250352544
2025-11-20

TREATMENT OF MUSCLE ATROPHY USING GSK-3 INHIBITORS

#1149
20250352542
2025-11-20

TRPV2 CHANNEL BLOCKERS AND USE THEREOF

#1150
20250352536
2025-11-20

NEURORESTORATION COMPOSITIONS IMPLEMENTING MULTIPLE NEUROPLASTICITY INDUCING MECHANISMS OF ACTION

#1151
20250352531
2025-11-20

Dosage Regimen for the Treatment of Cancer

#1152
20250352526
2025-11-20

TOPICAL ROFLUMILAST FORMULATION HAVING ANTIFUNGAL PROPERTIES

#1153
20250352511
2025-11-20

METHODS OF TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS WITH ATRASENTAN

#1154
20250352510
2025-11-20

LYMPH DIRECTING PRODRUGS

#1155
20250352501
2025-11-20

Methods Of Treatment Of Inflammation Related Conditions Using Pluripotent Anti-inflammatory And Metabolic Modulators

#1156
20250352493
2025-11-20

HIGHLY ELASTIC PATCHES AND MASKS FOR DELIVERY OF THERAPEUTIC AGENTS

#1157
20250352483
2025-11-20

Biomimetic Drug Delivery Particles

#1158
20250352480
2025-11-20

TAMPER RESISTANT DOSAGE FORMS

#1159
20250352472
2025-11-20

LIPID NANOPARTICLE (LNP) COMPOSITIONS FOR PLACENTA-SELECTIVE CARGO DELIVERY, AND METHODS OF USE THEREOF

#1160
20250347700
2025-11-13

METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS

#1161
20250346910
2025-11-13

METHODS AND COMPOSITIONS TO PREVENT MICROBIAL INFECTION

#1162
20250346901
2025-11-13

5-HALOURACIL-MODIFIED MICRORNAS AND THEIR USE IN THE TREATMENT OF CANCER

#1163
20250346670
2025-11-13

METHODS OF TREATING CANCER BY ADMINISTERING A NEOADJUVANT PD-1 INHIBITOR

#1164
20250346666
2025-11-13

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

#1165
20250346664
2025-11-13

MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)

#1166
20250346661
2025-11-13

DUAL SPECIFIC ANTIBODIES

#1167
20250346627
2025-11-13

URSOLIC ACID DIETHANOLAMINE SALT

#1168
20250346626
2025-11-13

COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE

#1169
20250346616
2025-11-13

ROCK INHIBITORS AND USES THEREOF

#1170
20250346598
2025-11-13

HETEROARYL-BIPHENYL AMINES FOR THE TREATMENT OF PD-L1 DISEASES

#1171
20250345461
2025-11-13

METHOD FOR REPAIRING HAIR CYCLE-RELATED GENES AND METHOD FOR TREATING HAIR CYCLE-RELATED DISEASES USING MIR-520D-5P

#1172
20250345450
2025-11-13

ANTIBODY-MEDIATED CONDITIONING WITH IMMUNOSUPPRESSION TO ENABLE ALLOGENEIC TRANSPLANTATION

#1173
20250345447
2025-11-13

PHARMACEUTICAL COMPOSITION OF RECOMBINANT ANTI-HUMAN CLDN18.2 MONOCLONAL ANTIBODY-MMAE CONJUGATE

#1174
20250345411
2025-11-13

VACCINATION IN NEWBORNS AND INFANTS

#1175
20250345410
2025-11-13

VACCINATION IN NEWBORNS AND INFANTS

#1176
20250345404
2025-11-13

COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE

#1177
20250345401
2025-11-13

TOPICAL THERAPEUTIC FORMULATIONS

#1178
20250345391
2025-11-13

COMPOSITIONS AND METHODS FOR THE TREATMENT OF SEPSIS

#1179
20250345388
2025-11-13

BINDING MOLECULES TO TUMOR ASSOCIATED MACROPHAGES AND METHODS OF USE

#1180
20250345374
2025-11-13

METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE USING BACILLUS AMYLOLIQUEFACIENS

#1181
20250345369
2025-11-13

ENGINEERED IMMUNOSTIMULATORY BACTERIAL STRAINS AND USES THEREOF

#1182
20250345352
2025-11-13

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#1183
20250345349
2025-11-13

CANNABINOIDS IN THE TREATMENT OF EPILEPSY

#1184
20250345341
2025-11-13

4-Pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament

#1185
20250345335
2025-11-13

METHODS OF TREATING AND PREVENTING GRAFT VERSUS HOST DISEASE

#1186
20250345333
2025-11-13

THERAPIES WITH PPAR AGONISTS AND FGFR4 INHIBITORS

#1187
20250345322
2025-11-13

NOVEL COMBINATION THERAPY OF CRENOLANIB AND APOPTOSIS PATHWAY AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS

#1188
20250345318
2025-11-13

COMPOUND AND USE THEREOF IN PREVENTING OR TREATING RADIATION DAMAGE

#1189
20250345317
2025-11-13

New pharmaceutical compounds, methods and uses thereof

#1190
20250345316
2025-11-13

METHODS OF INCREASING LYMPHOCYTE TRAFFICKING TO THE COLON BY STIMULATING RETINOIC ACID RECEPTORS AND ARYL HYDROCARBON RECEPTORS

#1191
20250345309
2025-11-13

IMMUNE HEALTH IMPROVERS

#1192
20250345308
2025-11-13

COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING CONDITIONS

#1193
20250345305
2025-11-13

Extended Duration Local Anesthetic Formulation

#1194
20250345304
2025-11-13

ASYMMETRIC SYNTHESIS AND USES OF COMPOUNDS IN DISEASE TREATMENTS

#1195
20250345303
2025-11-13

THERAPEUTIC COMPOSITIONS

#1196
20250345291
2025-11-13

METHOD OF TREATING POST-TRAUMATIC STRESS DISORDER

#1197
20250345288
2025-11-13

Arterial Application of Low Dose Ethyl Alcohol Enables Blood-Brain Barrier (BBB) Transient Opening

#1198
20250345287
2025-11-13

COMPOSITION COMPRISING A MIXTURE OF AT LEAST ONE OIL AND ONE OR MORE SEMIFLUORINATED ALKANES, A USE OF THE COMPOSITION FOR TREATING A DISEASE AS WELL AS A METHOD OF PRODUCING THE COMPOSITION AND CORRESPONDING KITS

#1199
20250345269
2025-11-13

PACKAGING FOR RAPIDLY INFUSING COMPOSITION

#1200
20250345267
2025-11-13

CHEWABLE PHARMACEUTICAL DOSAGE FORMS